Philip D. Edwards
AstraZeneca (United States)(US)
Publications by Year
Research Areas
Chemical Synthesis and Analysis, Computational Drug Discovery Methods, Cell Adhesion Molecules Research, Peptidase Inhibition and Analysis, Protease and Inhibitor Mechanisms
Most-Cited Works
- → Application of Fragment-Based Lead Generation to the Discovery of Novel, Cyclic Amidine β-Secretase Inhibitors with Nanomolar Potency, Cellular Activity, and High Ligand Efficiency(2007)211 cited
- → Synthetic Inhibitors of Elastase(1994)210 cited
- → Discovery of a Novel Warhead against β-Secretase through Fragment-Based Lead Generation(2007)148 cited
- → Linear Non-competitive Inhibition of Solubilized Human γ-Secretase by Pepstatin A Methylester, L685458, Sulfonamides, and Benzodiazepines(2002)145 cited
- → Design, synthesis, and kinetic evaluation of a unique class of elastase inhibitors, the peptidyl .alpha.-ketobenzoxazoles, and the x-ray crystal structure of the covalent complex between porcine pancreatic elastase and Ac-Ala-Pro-Val-2-benzoxazole(1992)144 cited
- → Application of Fragment Screening by X-ray Crystallography to the Discovery of Aminopyridines as Inhibitors of β-Secretase(2007)142 cited
- → An Integrated Approach to Fragment-Based Lead Generation:Philosophy, Strategy and Case Studies from AstraZenecas Drug Discovery Programmes(2007)127 cited
- → Conversion of Cystitis Glandularis to Adenocarcinoma(1972)110 cited
- → .alpha.-Amino carbanions via formamidines. Alkylation of pyrrolidines, piperidines, and related heterocycles(1984)109 cited
- → 2 Inhibitors of Human Leukocyte Elastase(1994)77 cited